← Back to Search

Melatonin Receptor Agonist

melatonin for Diabetes

N/A
Waitlist Available
Led By Frank AJL Scheer, PhD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age: 21-55 years of age
Body Mass Index: 20 and 35 kg/m2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 2, 3, 4 and/or 5 of the in-lab protocol
Awards & highlights

Study Summary

This study is evaluating whether melatonin and a specific gene variation may be related to blood sugar regulation.

Eligible Conditions
  • Diabetes
  • Circadian Rhythm
  • Melatonin
  • Genetics

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 2, 3, 4 and/or 5 of the in-lab protocol
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 2, 3, 4 and/or 5 of the in-lab protocol for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change in disposition index
Secondary outcome measures
Insulin
change in glucose tolerance
change in insulin sensitivity

Trial Design

2Treatment groups
Experimental Treatment
Group I: placebo-melatoninExperimental Treatment2 Interventions
subjects will receive placebo first and melatonin second
Group II: melatonin-placeboExperimental Treatment2 Interventions
subjects will receive melatonin first and placebo second
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
melatonin
2013
Completed Phase 3
~2260
placebo
2010
Completed Phase 4
~6580

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,600 Previous Clinical Trials
11,462,905 Total Patients Enrolled
30 Trials studying Diabetes
1,977,932 Patients Enrolled for Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,342 Previous Clinical Trials
4,314,226 Total Patients Enrolled
107 Trials studying Diabetes
138,663 Patients Enrolled for Diabetes
Frank AJL Scheer, PhDPrincipal Investigator - Brigham and Women's Hospital
Brigham and Women's Hospital
4 Previous Clinical Trials
431 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Mar 2025